We are live on ! Find out more
NTRA icon

Natera

137 hedge funds and large institutions have $1.83B invested in Natera in 2019 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 30 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

77% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 30

71% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 24

59% more capital invested

Capital invested by funds: $1.15B → $1.83B (+$682M)

12% more funds holding

Funds holding: 122137 (+15)

6.53% more ownership

Funds ownership: 89.03%95.56% (+6.5%)

10% less call options, than puts

Call options by funds: $1.42M | Put options by funds: $1.58M

Holders
137
Holders Change
+15
Holders Change %
+12.3%
% of All Funds
2.96%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
41
Increased
53
Reduced
30
Closed
24
Calls
$1.42M
Puts
$1.58M
Net Calls
-$162K
Net Calls Change
+$348K

NTRA Hedge Fund Activity: Q2 2019 in Review

137 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Natera (NTRA) for Q2 2019, worth a combined $1.83B — up 59% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new NTRA positions and 24 closed out — a net gain of 17 holders — while 53 added to existing stakes and 30 trimmed.

The largest buyer was OrbiMed, adding an estimated $47.4M. The largest seller was First Manhattan, exiting entirely with an estimated $21.2M sold.

  • 137 institutional investors held Natera (NTRA) as of Q2 2019, up from 122 in Q1 2019.
  • Funds reported $1.83B of Natera stock for Q2 2019, up 59% quarter-over-quarter.
  • 41 funds opened new Natera positions in Q2 2019 and 24 closed out, a net change of +17 holders.
  • The largest Natera buyer in Q2 2019 was OrbiMed, an estimated $47.4M added.
  • The largest Natera seller in Q2 2019 was First Manhattan, an estimated $21.2M sold.

Based on aggregated 13F filings for Q2 2019.